mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.006 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.006 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.007 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.007 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |